Using Supercomputers
to Checkmate Cancer
Gavilán Biodesign's ability to out-maneuver resistance, using AI technology to design drugs with a property called resistance-resilience, has the potential to change the way drugs are made.
Learn More
Using Supercomputers to Checkmate Cancer
Gavilán Biodesign's ability to out-maneuver resistance, using AI technology to design drugs with a property called resistance-resilience, has the potential to change the way drugs are made.
Innovation Hub Brings Together
Duke & Microsoft in Durham
Leaders from Duke University gathered together with counterparts from Microsoft from across the country in downtown Durham this month to celebrate the opening of a new collaborative “Innovation Hub” in the Chesterfield building.
Learn more
NEWS
Innovation Hub Brings Together Duke & Microsoft in Durham
A $500,000 loan from the North Carolina Biotechnology Center will help medical device company InnAVasc move forward with their clinical trials for its hemodialysis graft.
AskBio: 1st Patient in Phase
1/2 Study–Pompe Disease
Initial clinical study to evaluate ACTUS-101 over 52 weeks that could improve quality of life for those who are affected with rare genetic disorder - Pompe Disease.
Learn More
TECH TRANSFER NEWS
AskBio: 1st Patient Dosed in Phase 1/2 Study for Pompe Disease
Initial clinical study to evaluate ACTUS-101 over 52 weeks that could improve quality of life for those who are affected with rare genetic disorder - Pompe Disease.
Our 2018 Annual Report has arrived!
Discover the incredible things the Duke Office of Licensing and Ventures is accomplishing.
Learn More
BY THE NUMBERS
Our 2018 Annual Report has arrived!
Discover the incredible things the Duke Office of Licensing and Ventures is accomplishing.
Mentors-in-Residence: Successful 1st Year
Since its creation just a short year ago, the MIRs have helped Duke New Ventures advance numerous start-up ventures into the marketplace, creating an impact on the local economy.
Mentors-in-Residence: Successful 1st Year
Since its creation just a short year ago, the MIRs have helped Duke New Ventures advance numerous start-ups ventures into the marketplace, creating an impact on the local economy.
Learn More
The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University
Take the first step
The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University
Take the first step
The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University
Take the first step
